Morning Gainers for Mar. 3, 2014: DNDN, PERI, RVNC, ARRY, OMEX, NIHD

By: via Benzinga
Dendreon (NASDAQ: DNDN ) - up 19% - Reports Q4 EPS of $(0.17) vs $(0.37) Est; Revenue of $74.80M vs $73.59M Est. Perion Network (NASDAQ: PERI ) - up 13.5% - Reports Q4 2013 Revenue of $31.3M, 47% YoY increase. EBITDA increased 56% YoY reaching $25.5M. Revanece Therapeutics (NASDAQ:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.